Medtronic Plc

NYSE:MDT  
90.23
+1.56 (+1.76%)
4:02:17 PM EDT: $90.29 +0.06 (+0.07%)
Other Pre-Announcement

Medtronic Reports Full Year And Fourth Quarter Fiscal Year 2022 Financial Results

Published: 05/26/2022 11:00 GMT
Medtronic Plc (MDT) - Medtronic Reports Full Year and Fourth Quarter Fiscal Year 2022 Financial Results; Announces 8% Dividend Increase.
Q4 Non-GAAP Earnings per Share $1.52.
Q4 GAAP Earnings per Share $1.10.
Sees FY Non-GAAP Earnings per Share $5.53 to $5.65 Including Items.company Issues FY23 Guidance.
Q4 Results Affected by Temporary Global Supply Chain Impacts and China Lockdowns.
Mid-single Digit FY22 Revenue Growth; Q4 Results Affected by Temporary Global Supply Chain Impacts and China Lockdowns.
Q4 Revenue of $8.1 Billion Decreased 1% Reported and Increased 1% Organic.
Global Supply Chain and Covid-19 Controls in China Created Acute Impacts to Our Results in Q4.
Neuroscience Q4 Revenue of $2.299 Billion Was Flat Year-over-year As Reported and Increased 2% Organic.
Q4 Cardiovascular Revenue of $2.961 Billion Increased 2% As Reported and 5% Organic.
Cranial & Spinal Technologies Q4 Revenue of $1.165 Billion Decreased 2% As Reported and 1% Organic.
Expects Organic Revenue Growth in Its Fiscal Year 2023 in Range of 4% to 5%.
Surgical Innovations Q4 Revenue of $1.491 Billion Decreased 3% As Reported and Was Flat Year-over-year Organic Due to Supply Constraints.
Medtronic - If Recent Foreign Currency Exchange Rates Hold, Fiscal Year 2023 Revenue Would Be Negatively Affected by About $1.0 Billion to $1.1 Billion.
Expects Fiscal Year 2023 Non-GAAP EPS in Range of $5.53 to $5.65.
Remains Committed to Returning a Minimum of 50 Percent of Its Free Cash Flow to Shareholders.